Clinical case of a patient with fatal development of gas gangrene while using totally implantable venous access devices

Gas gangrene, or clostridial myonecrosis, is a rare and life-threatening infection caused primarily by Clostridium perfringens . Despite its reduced incidence due to advancements in wound care and antibiotics, the disease remains associated with significant morbidity and mortality, particularly in immunocompromised individuals. This report presents a clinical case of a 37-year-old male with esophageal carcinoma and a totally implantable venous access device (Port-a-Cath), who developed fatal gas gangrene following chemotherapy. The patient presented with rapidly progressing symptoms, including fever, extensive edema, crepitus, and necrotic bullous lesions of the right upper limb and thoracic region. Despite prompt multidisciplinary evaluations and surgical intervention, the patient succumbed to infectious shock and cardiac arrest shortly after the initial incision. This case underscores the critical need for early clinical recognition of gas gangrene, especially by surgeons and emergency physicians, to initiate life-saving surgical debridement and adjunctive therapies. This report also highlights the interplay of modern medical devices with rare but catastrophic infections, emphasizing the necessity of vigilant monitoring and robust infection control protocols in high-risk patients. Through this unique presentation, we aim to enhance awareness and diagnostic acumen among healthcare professionals, advocating for interdisciplinary approaches and evidence-based guidelines to mitigate the devastating impact of gas gangrene in similar clinical contexts.